Issue 2, 2015

Digital Pharma - Responding to Challenges and Opportunities from Outside

Ulrica Sehlstedt, Nils Bohlin, Fredrik de Maré, Richard Beetz

Innovation has always been one of the foundations for success in the pharmaceutical industry. While the sector has been very good at developing innovation from scratch or incremental innovation of existing products, it now faces an ultimately different challenge ╨ dealing with disruptive innovation that is driven by inventions outside the healthcare sector. New players from the digital arena are currently redefining the way the industry works. In this article the authors outline the nature and origins of the disruptive pressure on the pharma sector and how companies should transform to respond to the challenges and opportunities arising from this new era of digitalization.

Search by keyword

About Prism

Twice a year, Arthur D. Little covers the latest cutting-edge thinking on strategy, technology and innovation in its corporate magazine Prism. For over 20 years Prism has continually set the standards in innovative thinking and groundbreaking concepts in the world of business and management.

Article Toolbar

RecommendFacebook|Twitter|LinkedIn

Download PDF , 0.9 MB

| |Bookmark Arthur D. Little